loadpatents
Patent applications and USPTO patent grants for Bollard; Catherine Mary.The latest application filed is for "ex vivo activated t-lymphocytic compositions and methods of using the same".
Patent | Date |
---|---|
Improved Targeted T-cell Therapy For Treatment Of Multiple Myeloma App 20220062342 - Bollard; Catherine Mary ;   et al. | 2022-03-03 |
Ex Vivo Activated T-lymphocytic Compositions And Methods Of Using The Same App 20220064598 - Bollard; Catherine Mary ;   et al. | 2022-03-03 |
Cells Expressing Antibodies Targeting Human Immunodeficiency Virus And Methods Of Using The Same App 20220048988 - Bollard; Catherine Mary ;   et al. | 2022-02-17 |
System Of Cell Expansion And Methods Of Using The Same App 20210371852 - Bollard; Catherine Mary ;   et al. | 2021-12-02 |
Improved Cell Therapy Compositions For Hematopoietic Stem Cell Transplant Patients App 20210213066 - Bollard; Catherine Mary ;   et al. | 2021-07-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.